To develop and bring to patients new targeted cancer chemotherapy drugs that have reduced side effects and improved
effectiveness compared to existing chemotherapy cancer drugs.
IGF Oncology, LLC, a Minnesota company registered in Delaware, was formed to develop its novel and proprietary family
of new anti-cancer chemotherapy drugs with reduced toxicity.
The company has now demonstrated in mice that its first candidate drug is more than six times better than the closest
conventional chemotherapy drug.
© IGF Oncology, LLC.